Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Vaxart, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 100 | 1 | 100 | +1 |
| Shares | 40.5M | 1.77M | 37.6M | −1.19M (−3.1%) |
| Value | $27.0M | $1.18M | $31.9M | +$6.03M (+23.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Vaxart, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,774,346 | $1.51M | 0.00% |
| Silverarc Capital Management, LLC | 1,000,000 | $849.0K | 0.19% |
| Squarepoint Ops LLC | 265,009 | $225.0K | 0.00% |
| Jane Street Group, LLC | 204,335 | $173.5K | 0.00% |
| Goldman Sachs Group Inc | 125,541 | $106.6K | 0.00% |
| Pale Fire Capital SE | 51,028 | $43.3K | 0.01% |
| Graham Capital Management, L.P. | 20,849 | $17.7K | 0.00% |
| Capital Advisory Group Advisory Services, LLC | 15,000 | $12.7K | 0.01% |
| Ground Swell Capital, LLC | 12,025 | $10.2K | 0.01% |
| Perigon Wealth Management, LLC | 10,000 | $8.49K | 0.00% |
| Carnegie Lake Advisors LLC | 10,000 | $8.00K | 0.00% |
| National Bank of Canada | 6,200 | $5.26K | 0.00% |
| GWM Advisors LLC | 444 | $377 | 0.00% |
| Federation des caisses Desjardins du Quebec | 400 | $340 | 0.00% |
| Country Trust Bank | 300 | $255 | 0.00% |
| Jones Financial Companies LLLP | 123 | $101 | 0.00% |
| SJS Investment Consulting Inc. | 3 | $3 | 0.00% |
| CWM, LLC | 10 | $0 | 0.00% |
Sold out (17)
Institutions that held Vaxart, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Alyeska Investment Group, L.P. | 1,250,000 | $834.1K |
| ADAR1 Capital Management, LLC | 945,568 | $631.0K |
| Renaissance Technologies LLC | 847,631 | $565.6K |
| Toroso Investments, LLC | 39,212 | $26.2K |
| Steward Partners Investment Advisory, LLC | 35,000 | $23.4K |
| Private Portfolio Partners LLC | 27,170 | $18.1K |
| RPg Family Wealth Advisory, LLC | 25,000 | $16.7K |
| Kingswood Wealth Advisors, LLC | 25,000 | $16.7K |
| Moors & Cabot, Inc. | 20,000 | $13.3K |
| Two Sigma Securities, LLC | 15,105 | $10.1K |
| Tamar Securities, LLC | 15,000 | $10.0K |
| Virtu Financial LLC | 13,328 | $9.00K |
| StoneX Group Inc. | 11,312 | $7.55K |
| Rhumbline Advisers | 5,264 | $3.51K |
| Financial Network Wealth Advisors LLC | 100 | $67 |
| Abich Financial Wealth Management LLC | 70 | $47 |
| CoreCap Advisors, LLC | 4 | $3 |
Not filed for Q3 2024 yet (1)
Institutions that held Vaxart, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,774,346 | $1.18M |